| HER3 comes of age: new insights into its functions and role in signaling, tumor biology, and cancer therapy MR Campbell, D Amin, MM Moasser Clinical Cancer Research 16 (5), 1373-1383, 2010 | 231 | 2010 |
| The role of HER3, the unpretentious member of the HER family, in cancer biology and cancer therapeutics DN Amin, MR Campbell, MM Moasser Seminars in cell & developmental biology 21 (9), 944-950, 2010 | 171 | 2010 |
| HER2 amplification in tumors activates PI3K/Akt signaling independent of HER3 A Ruiz-Saenz, C Dreyer, MR Campbell, V Steri, N Gulizia, MM Moasser Cancer research 78 (13), 3645-3658, 2018 | 106 | 2018 |
| Msh2 deficiency leads to chromosomal abnormalities, centrosome amplification, and telomere capping defect MR Campbell, Y Wang, SE Andrew, Y Liu Oncogene 25 (17), 2531-2536, 2006 | 57 | 2006 |
| DNA mismatch repair proteins promote apoptosis and suppress tumorigenesis in response to UVB irradiation: an in vivo study LC Young, KJ Thulien, MR Campbell, VA Tron, SE Andrew Carcinogenesis 25 (10), 1821-1827, 2004 | 45 | 2004 |
| HER family in cancer progression: From discovery to 2020 and beyond R Kumar, B George, MR Campbell, N Verma, AM Paul, C Melo-Alvim, ... Advances in cancer research 147, 109-160, 2020 | 33 | 2020 |
| A lack of DNA mismatch repair on an athymic murine background predisposes to hematologic malignancy MR Campbell, PN Nation, SE Andrew Cancer research 65 (7), 2626-2635, 2005 | 21 | 2005 |
| Effective treatment of HER2-amplified breast cancer by targeting HER3 and β1 integrin MR Campbell, H Zhang, S Ziaee, A Ruiz-Saenz, N Gulizia, J Oeffinger, ... Breast cancer research and treatment 155, 431-440, 2016 | 17 | 2016 |
| Extensive conformational and physical plasticity protects HER2-HER3 tumorigenic signaling MR Campbell, A Ruiz-Saenz, Y Zhang, E Peterson, V Steri, J Oeffinger, ... Cell reports 38 (5), 2022 | 10 | 2022 |
| HER targeting in HER2-negative breast cancers: looking for the HER3 positive MR Campbell, MM Moasser Clinical Cancer Research 21 (13), 2886-2888, 2015 | 10 | 2015 |
| Application of inter–simple sequence repeat PCR to mouse models: Assessment of genetic alterations in carcinogenesis F Benavides, M Zamisch, M Flores, MR Campbell, SE Andrew, JM Angel, ... Genes, Chromosomes and Cancer 35 (4), 299-310, 2002 | 10 | 2002 |
| Targetable HER3 functions driving tumorigenic signaling in HER2-amplified cancers MR Campbell, A Ruiz-Saenz, E Peterson, C Agnew, P Ayaz, S Garfinkle, ... Cell reports 38 (5), 2022 | 9 | 2022 |
| Candidate mutator genes in mismatch repair-deficient thymic lymphomas: no evidence of mutations in the DNA polymerase δ gene MR Campbell, TY Thang, FR Jirik, SE Andrew Carcinogenesis 21 (12), 2281-2285, 2000 | 3 | 2000 |
| The conditional requirement of HER3 in HER2-amplified breast cancers A Ruiz-Saenz, C Dreyer, V Steri, M Campbell, N Gulizia, M Moasser MOLECULAR CANCER RESEARCH 16 (8), 94-95, 2018 | | 2018 |
| Abstract B66: The conditional requirement of HER3 in HER2-amplified breast cancers A Ruiz-Saenz, C Dreyer, V Steri, M Campbell, N Gulizia, M Moasser Molecular Cancer Research 16 (8_Supplement), B66-B66, 2018 | | 2018 |
| PO-115 HER2-amplified tumours overcome the requirement for HER3 A Ruiz-Saenz, CA Dreyer, V Steri, MR Campbell, N Gulizia, MM Moasser ESMO Open 3, A65, 2018 | | 2018 |
| DNA mismatch repair, genome stability and tumorigenesis MR Campbell | | 2005 |
| The role of DNA mismatch repair defects in haematological malignancy. S Andrew, M Campbell, F Jirik, R Coupland AMERICAN JOURNAL OF HUMAN GENETICS 67 (4), 80-80, 2000 | | 2000 |
